INTRODUCTION
Methods for the detection of certain anabolic steroid drugs and their metabolites by radioimmunoassay have been developed by Professor R. V. Brooks and his associates during the last few years (Sumner, 1974 ).
Recently we have been examining the alternative analytical procedure of gas chromatography-mass spectrometry for the detection and identification of anabolic steroid drugs and their urinary metabolites.
Our three main objectives in this study were:-1. To characterise the major urinary metabolites of a number of anabolic steroid drugs.
2. To identify unequivocally drugs or their metabolites in urine samples obtained from athletes where radioimmunoassay had given positive results.
3. To develop procedures for the positive identification of drugs or drug metabolites for which radioimmunoassays do not yet exist.
EXPERIMENTAL
Collection of urine samples Investigation of metabolism of anabolic steroids: A control sample was collected prior to administration of 10 or 20 mg of the drug under investigation.* Thereafter urine was collected for the first 48 hours and then one sample each day for 7 days.
Identification of anabolic steroids in urine from athletes: Urine samples were collected from athletes attending the 1974 Commonwealth Games in Christchurch and the European Games held in Rome, 1974 . These specimens were analysed initially by Professor Brooks using radioimmunoassays and then submitted to us for independent assessment.
Steroid extraction and fractionation
The urine specimens were poured on to columns of Amberlite XAD-2 resin to extract free and conjugated 
RESULTS AND DISCUSSION
We restricted our study of anabolic steroid metabolism to those compounds illustrated in Fig. 1 . Their metabolism and detection will be described in each compound in the following sections. 
Dianabol
The mass spectra of the silyl ethers of Dianabol and its major urinary metabolite, 6j-hydroxy-Dianabol (Rongone, 1963) , are shown in Fig. 2 . The principal fragmentation is across the D-ring giving rise to a peak at m/e 143. This ion is present in metabolites of Dianabol (Lawson, 1971) and in other anabolic steroids with the same D-ring substitution. Although m/e 143 is a characteristic ion in these cases it is not unique and arises from different sources in several endogenous steroids. However, if m/e 143 is monitored while a derivatised urine sample, containing 63-hydroxy-Dianabol, is eluting from the gas chromatograph into the mass spectrometer, a response at the gas chromatographic retention time of 63-hydroxy-Dianabol is sufficiently specific to identify its presence (Lawson, 1971 The screening method we adopted to detect the presence of 63-hydroxy-Dianabol in urine samples from athletes comprised an initial fractionation stage using Sephadex LH-20 followed by trimethylsilylation and then selected ion monitoring of m/e 209. The chromotograms from these, together with undrugged urine control samples are shown in Fig. 3 . The two controls show no evidence of a m/e 209 peak while two of the athlete samples have response peaks with the correct retention time for 63-hydroxy-Dianabol. This was good evidence that Dianabol had been taken by these two athletes. Full mass spectral scans of the region in question provided complete confirmation of the presence of 6j3-hydroxyDianabol by comparison with an authentic reference mass spectrum. Later we learned that these two samples had given a positive response to the radioimmunoassay for a 1 7-hydroxy-1 7-methyl steroid.
We investigated these samples further using the repetitive scanning technique. Although this is less sensitive than selected ion monitoring, by one to two orders of magnitude, it does have several advantages. These are that complete spectra are available for all gas chromatographic peaks, no preselection of ions is necessary and selected ions for any drug metabolite can be searched for in the acquired data. From the repetitive scanning data, acquired from the two positive Commonwealth Games samples, ions m/e 143, 209, 281 and 460 were plotted against scan number (Fig. 4) and the expected confirmatory responses obtained for 63-hydroxy-Dianabol at the correct retention time. The main point to be made is that this data could be searched for any of the characteristic ions listed in Table I and the identity be obtained rapidly of the specific drug ingested. Alternatively it would be possible to identify drug or drug metabolite peaks automatically using a computer held library of reference spectra. We investigated the remaining drugs, Stromba, Orabolin, Nilevar and Durabolin (Fig. 1) Unfortunately difficulty has been found in detecting Stromba or its urinary metabolites following administration of the drug. In addition the trimethylsilyl ether of Stromba has poor gas chromatographic properties due to the polarity of the pyrazole ring. Further investigation of the metabolism of this drug is in progress by administering high doses of Stromba to a primate species Callithrix jacchus). Normally this monkey has a low steroid excretion, so any Stromba metabolites should be more apparent and these may be later sought in human urine.
Durabolin
Since the ester group of Durabolin is rapidly removed in the body to form 19-nor-testosterone the same methods are applicable for the analysis of both anabolic steroids. Although small amounts of 19-nor-testosterone were identified in urine following administration of Durabolin, the major metabolite was found to give a mass spectrum suggesting the structure 19-nor-aetiocholanolone or 19-nor-androsterone. Miedema et al. (1972) , Dimick (1961) and Engel (1958) also report the conversion of 19-nor-testosterone to these 1 7-oxo-steroids and report a small increase in the excretion of oestrogens. However, in our study we were unable to detect either oestrone or oestradiol in the urine samples.
The major fragmentation ions of the silyl ether of the 19-nor-17-oxo-steroid were at m/e 257 and m/e 258 (M-90). Although these ions are also given by endogenous androsterone and aetiocholanolone the 19-nor-testosterone metabolite may be distinguished by its shorter retention time on gas chromatographic analysis. It was found that multiple ion detection of m/e 257, 258, 333 and 348 together with retention time data gives a specific determination of the 19-nor-testosterone metabolite. It was of interest that the metabolite could still be detected in urine 8 days after administration of the drug.
Orabolin
The equivalent ion in the spectrum of Orabolin-trimethylislyl ether (Fig. 6) to the m/e 143 in Dianabol-trimethylsilylether, occurs at m/e 157. Initially this was used, together with m/e 144, to detect any urinary metabolites with an unchanged D-ring. Several hydroxylated metabolites were observed in this way and partially characterised from their mass spectra. However, the major metabolite peak did not have the m/e 157 and 144 ions and instead showed ions m/e 245 and 231. This indicated a modified D-ring with the fragmentation shown in Fig. 7 demonstrating this to be 21-hydroxylation. Similar hydroxylation of the alkyl side-chain has also been reported for allylestrenol and Nilevar (Thyssen, 1967; Brooks et al., 1971) . Another anabolic steroid, Nilevar was also shown to be an important metabolite of Orabolin and the 21-hydroxylated metabolite of Orabolin was also obtained in urine following ingestion of Nilevar. The proposed conversion of Orabolin and Nilevar to the major metabolite is illustrated in Fig. 8 . This metabolite can be conveniently detected by repetitive scanning GC-MS and selecting the ions m/e 421, 331, 241 and 245. 
Nilevar
The metabolism of Nilevar has been investigated previously by GC-MS using single ion monitoring by Brooks and co-workers (1971) . In the present study a number of metabolites were found with the principal one being the 19-nor-pregnanetriol identified as the major metabolite of Orabolin. 
CONCLUSIONS

